Acumen Pharmaceuticals Inc Financial Flexibility Index
Acumen Pharmaceuticals Inc financial flexibility index. Acumen Pharmaceuticals Inc (ABOS) has a Financial Flexibility Index of -0.52x as of March 2026. Free cash flow of $-24.13 Million (operating CF $-24.13 Million minus capex $0.00) represents -1% of total liabilities ($46.15 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Acumen Pharmaceuticals Inc (2019–2025)
Financial flexibility index of Acumen Pharmaceuticals Inc from 2019 to 2025. Historical Financial Flexibility Index trend for Acumen Pharmaceuticals Inc across 7 annual periods. Explore how well can Acumen Pharmaceuticals Inc service its debt to assess how comfortably operating cash covers total debt obligations.
Acumen Pharmaceuticals Inc Financial Flexibility Index by Year (2019–2025)
Acumen Pharmaceuticals Inc financial flexibility index by year from 2019 to 2025. Year-by-year free cash flow to debt coverage for Acumen Pharmaceuticals Inc. For the full cash flow conversion analysis, see Acumen Pharmaceuticals Inc cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.20x | $-115.45 Million | $-115.54 Million | $52.40 Million | ▼ -46.1% |
| 2024 | -1.51x | $-86.20 Million | $-86.22 Million | $57.18 Million | ▼ -51.1% |
| 2023 | -1.00x | $-43.04 Million | $-43.06 Million | $43.15 Million | ▲ +77.7% |
| 2022 | -4.48x | $-34.99 Million | $-35.15 Million | $7.81 Million | ▼ -28.6% |
| 2021 | -3.48x | $-17.92 Million | $-17.96 Million | $5.15 Million | ▼ -2861.2% |
| 2020 | -0.12x | $-7.41 Million | $-7.45 Million | $63.02 Million | ▲ +67.5% |
| 2019 | -0.36x | $-6.78 Million | $-6.82 Million | $18.74 Million | — |